Athira Pharma Inc (ATHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 6,874 | 7,291 | 9,536 | 15,566 | 29,621 |
| Operating Income | -6,874 | -7,291 | -9,536 | -15,566 | -29,621 |
| Other Income | 263 | 325 | 393 | 563 | 880 |
| Pre-tax Income | -6,611 | -6,966 | -9,143 | -15,003 | -28,741 |
| Net Income Continuous | -6,611 | -6,966 | -9,143 | -15,003 | -28,741 |
| Net Income | $-6,611 | $-6,966 | $-9,143 | $-15,003 | $-28,741 |
| EPS Basic Total Ops | -1.68 | -1.80 | -2.30 | -3.84 | -7.46 |
| EPS Basic Continuous Ops | -1.68 | -1.78 | -2.34 | -3.86 | -7.46 |
| EPS Diluted Total Ops | -1.68 | -1.80 | -2.30 | -3.84 | -7.46 |
| EPS Diluted Continuous Ops | -1.68 | -1.78 | -2.34 | -3.86 | -7.46 |
| EPS Diluted Before Non-Recurring Items | -1.68 | -1.80 | -2.30 | -3.90 | -7.50 |
| EBITDA(a) | $-6,701 | $-7,175 | $-9,358 | $-15,350 | $-29,435 |